Drugs / Drospirenone/Ethinyl Estradiol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01805817 | Dec 2012 → Dec 2013 | — | Istanbul Training and Research Hospital | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Drospirenone/Ethinyl Estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01805817 ↗ |
| Known as | YASMIN | “YASMIN® (Drospirenone/Ethinyl Estradiol)” NCT01805817 ↗ |
| Route | Oral | “oral contraceptive pills” NCT01805817 ↗ |